- Release Date: 10/10/24 09:04
- Summary: Osteopore strikes scaffold-based iPSC deal with RxCell
- Price Sensitive: No
- Download Document 387.48KB
- Forums
- ASX - By Stock
- Ann: Osteopore strikes scaffold-based iPSC deal with RxCell
Ann: Osteopore strikes scaffold-based iPSC deal with RxCell
Featured News
Add OSX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $4.622M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 3.9¢ | $3.334K | 84.85K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 240000 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 61470 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300000 | 0.039 |
2 | 301800 | 0.038 |
6 | 260631 | 0.037 |
5 | 266665 | 0.036 |
1 | 28571 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 61470 | 3 |
0.041 | 104142 | 2 |
0.042 | 620000 | 3 |
0.043 | 25000 | 1 |
0.045 | 55846 | 1 |
Last trade - 14.33pm 13/11/2024 (20 minute delay) ? |
Featured News
OSX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online